Epidermal growth factor receptor targeting in cancer: a review of trends and strategies.
about
MLK3 Signaling in Cancer InvasionEpidermal growth factor, from gene organization to bedsideThe adaptor protein CIN85 assembles intracellular signaling clusters for B cell activationStructural basis of selectivity and neutralizing activity of a TGFα/epiregulin specific antibodyMolecular imaging of EGFR/HER2 cancer biomarkers by protein MRI contrast agentsUsing high-throughput sequencing transcriptome data for INDEL detection: challenges for cancer drug discovery.Outcome of gemcitabine plus molecular targeted agent for treatment of pancreatic cancer: a meta-analysis of prospective phase III studies.Patient considerations in metastatic colorectal cancer - role of panitumumab.Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells.Nimotuzumab in combination with radiotherapy in high grade glioma patients: a single institution experience.Highly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb Antibodies.Synthesis of BODIPY-Peptide Conjugates for Fluorescence Labeling of EGFR Overexpressing Cells.Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expression.Coexpression of EGFR and CXCR4 predicts poor prognosis in resected pancreatic ductal adenocarcinoma.Nephrotoxicity of recent anti-cancer agents.Biomarkers of erlotinib response in non-small cell lung cancer tumors that do not harbor the more common epidermal growth factor receptor mutations.Cell-Based High-Throughput Screening for Aromatase Inhibitors in the Tox21 10K LibraryEpidermal growth factor receptor pathway mutation and expression profiles in cervical squamous cell carcinoma: therapeutic implications.Immunology and Immunotherapy of Head and Neck CancerThe relevance of molecular biomarkers in cervical cancer patients treated with radiotherapy.Cetuximab combined with chemotherapy is beneficial for patients with advanced non-small cell lung cancer after EGFR-tyrosine kinase inhibitors failure.Polymeric oncolytic adenovirus for cancer gene therapy.Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression.Sensing of p53 and EGFR Biomarkers Using High Efficiency SERS Substrates.Breast Cancer Heterogeneity Examined by High-Sensitivity Quantification of PIK3CA, KRAS, HRAS, and BRAF Mutations in Normal Breast and Ductal CarcinomasThe status of epidermal growth factor receptor in borderline ovarian tumours.Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric cancer therapy.Novel targeted therapies in adrenocortical carcinoma.Nimotuzumab combined with concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a retrospective analysis.Varying effects of EGF, HGF and TGFβ on formation of invadopodia and invasiveness of melanoma cell lines of different originA phase II study of concurrent chemoradiotherapy and erlotinib for inoperable esophageal squamous cell carcinomaIdentification of the zinc finger 216 (ZNF216) in human carcinoma cells: a potential regulator of EGFR activity.Tyrosine kinase domain mutations of EGFR gene in head and neck squamous cell carcinoma.Chimeric antigen receptor T cells: a novel therapy for solid tumors.Therapeutic resistance in cancer: microRNA regulation of EGFR signaling networks.Viruses exploit the function of epidermal growth factor receptor.Modular nanotransporters for targeted intracellular delivery of drugs: folate receptors as potential targets.ErbB receptors as prognostic and therapeutic drug targets in bone and soft tissue sarcomas.Epidermal growth factor receptor imaging in human head and neck cancer xenografts.Emerging molecular targets and therapy for cholangiocarcinoma.
P2860
Q26746892-85E141C7-D9AB-4759-B21B-6EB7D40EFF98Q26865616-2CD3919D-0E33-4805-B34D-2B6DE6CD74F5Q27714533-A0E47058-01D7-4ECA-871C-4E925D97578FQ27727718-1292DA4C-5813-4BC0-860D-D93501FCA349Q28304646-DEBA59E9-2139-4D2D-9828-60564F23F9FBQ31038214-BE9E1003-BBB8-4A78-8B72-30647EFD4C6DQ33417105-4288A74C-3EAE-40D9-8A0F-64410BB4397DQ33563293-3DDB3308-DDAB-4684-82EA-BBFEF9AAA0E5Q33604480-8718560E-D526-44A6-9C97-EC1AA5B7F50CQ33631435-59BF78D1-F35C-45B5-9C17-B548BC3D6D87Q33721106-32BD5A57-3ED0-4967-9B97-5E4B8D086BB8Q33898658-5A3454B2-D279-4601-B0E6-0DA62FF91C3EQ34538361-88911DCC-82C4-41D5-BF98-6B84FC85FBBEQ35095399-4CB4D3F9-8BF0-4AF1-8AA3-A1ADF4AAE046Q35310741-FDD2370D-D496-4BF6-A1A5-A482FD50820CQ35632206-44A5D899-6B0D-4B3E-9251-40BA67826603Q35682481-68924A63-2266-4CFE-A657-DE84EFF9BED2Q35885555-957EEF81-6772-4BA9-A369-801C773E03D4Q36100837-6DEB325F-E520-4EB3-A0BF-B9E72701BEFAQ36241881-23D0A0E0-0D49-43B3-9F36-9D778D885B63Q36317864-B4024EFB-E973-4528-9B06-6B4C618DDCB0Q36344901-40BC40E9-5989-4D4F-BF0E-FA53D3BFD40CQ36357543-BAFA3593-16D7-453F-95AF-6957AB384DEAQ36419208-A0AC94AE-5B9B-4953-84BE-C79701AF14A1Q36823916-240AFE9F-B050-4298-B401-7989BA0638CAQ36963030-9E7DCFD3-9CAF-409D-8A81-82A010166577Q37224751-EAC141B0-7EB1-4248-90F3-0EDF7A61C648Q37233378-09004BD0-D691-4ECB-A3A7-FC9B768482C7Q37269328-1F063633-F954-4723-8E4C-672E858D4528Q37527128-301F552A-B326-46C4-BB95-B387DBF7EBDDQ37636802-C8511857-625F-40AD-987C-EC3D4A68F149Q37688876-5AEB67E8-E4B8-44B3-8A10-3B633CCEDFB8Q37712380-7186FA87-88B2-422F-B1DB-A3EB4C7ED24FQ37728639-CCF2C7B7-FB17-4D65-87DD-917070F72647Q38172182-0BB86FFD-8A9D-4DA8-9FD3-6C1867ADA549Q38216860-2AEE3EC1-3E86-49B9-ABB0-584F522D1E47Q38259956-5ACB5DE2-4450-41D2-8895-DCC0348F5ECCQ38263000-EC487C27-FC46-4191-B9ED-35492A24347EQ38561772-9B292DB2-DDE7-45DB-9B72-2160561A2908Q38642455-2C94D78A-CAAF-4354-86DE-D4493269B2D7
P2860
Epidermal growth factor receptor targeting in cancer: a review of trends and strategies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Epidermal growth factor receptor targeting in cancer: a review of trends and strategies.
@en
type
label
Epidermal growth factor receptor targeting in cancer: a review of trends and strategies.
@en
prefLabel
Epidermal growth factor receptor targeting in cancer: a review of trends and strategies.
@en
P2093
P1433
P1476
Epidermal growth factor receptor targeting in cancer: a review of trends and strategies
@en
P2093
Chetan Yewale
Dipesh Baradia
Sushilkumar Patil
P304
P356
10.1016/J.BIOMATERIALS.2013.07.100
P577
2013-08-13T00:00:00Z